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CARDIOVASCULAR EFFECTS OF POTASSIUM,
CALCIUM, MAGNESIUM, AND BARIUM
AN EXPERIMENTAL STUDY OF TOXICITY AND RATIONALE OF
USE IN THERAPEUTICS*
A. W. WINKLER, H. E. HOFF, AND P. K. SMITH
Therapeutic application of the specific pharmacological proper-
ties of certain cations has been made frequently. Intravenous injec-
tion of calcium chloride has long been used for the relief of certain
types of tetany;'8 magnesium sulfate injections have been widely
employed in the relief of convulsions;2 it has been stated that the
injection of magnesium salts may control certain cardiac arrhyth-
mias;28 barium chloride by mouth has been recommended in the
treatment of heart block;4 and renewed interest in the toxicity of
potassium has resulted from its association with cortical adrenal
inisufficiency.'0 Conventional statements regarding the physiological
effects of these ions frequently fail to distinguish between the
responses of the mammalian and of the amphibian heart. So little
attention has been paid to quantitative considerations that disturb-
ances produced only by large amounts of a salt have been attributed
to the administration of much smaller amounts. The resultant con-
fusion has led to certain misconceptions.
'Accordingly, the effects upon the mammalian cardiovascular sys-
tem ofsalts ofpotassium, calcium, magnesium, and barium have been
made the subject of a systematic quantitative study.7'8"18"19o20 24 25
Dogs and cats under morphine and local anesthesia were employed.
The chlorides or sulfates of these elements were injected at a slow,
uniform rate until death. Serial electrocardiograms were taken dur-
ing the course of injection, and arterial blood pressure was continu-
ously recorded. At intervals during injection the concentration in
the serum of the ion being injected was measured. From these
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values the concentration in the serum of the ion corresponding to
each effect could be obtained by interpolation. The only exception
to this procedure was made with respect to barium, for which no
suitable method was available.
CONTROL
ELEVATION OF T WAVE
28 Ak A
S-T DEPRESSION LOSS OF P
40
INTRAVENTRICULAR BLOCK
The details of these experiments
have been reported elsewhere. The
present paper summarizes the re-
sults and considers their possible
clinical implications.
Results
The effects of each ion are sum-
marized in tabular form on page
130. Figures 1, 2, 3, and 4 illus-
trate the changes in pattern of the
electrocardiographic complexes.
Potassium
The essential results of the
PRONOUNC ED BLOCK animal experiments which seem ap-
48 / plicable to man may be briefly
summarized:
1. The two characteristic toxic
ARREST effects on the heart of the slow
56 intravenous injection of potassium
are block (beginning at a concentra-
FIG. 1. A diagram showing the pro- tion ofpoasu inteerm f gressive changes that occur in the elec- potassium in the serum of
trocardiogram (Lead II) of the dog as 40 mg. per cent) and arrest.
an isotonic solution of potassium chlor- 2. Ventricular fibrillation has
ide is injected 'intravenously at a slow
rate. At the left is given the average been- observed only after the rapid
level of serum potassium at which the injection of concentrated solutions
various changes occur. The P waveineonfcnetredslin.
diminishes in amplitude and widens pro- 3. Blood pressure is unaffected
gressively, and just before it disappears until the onset of widespread intra-
(not shown here) various stages of A-V
blodk may be seen. ventncular block immediately pre-
ceding arrest.
4. Immediate reversal of all effects follows cessation of
injections before terminal stages have been reached.
Dangerous toxic effects in the dog did not appear until the con-
centration of potassium had increased to more than twice its usual
level. In normal man it is difficult to produce even a slight increase
in the serum potassium by the oral administration of potassium
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salts."4 Intravenous injection is not feasible, since even isotonic
solutions of potassium salts are locally very irritating when injected
by this route.2" Excretion in the urine is normally very rapid, while
the gastro-intestinal tract will tolerate potassium salts only in rela-
tively small amounts. As little as five grams of potassium chloride
in a single dose may produce abdominal discomfort, and larger
quantities are apt to induce nausea and vomiting.23 Because of the
relatively slow excretion of potassium in renal insufficiency, the pos-
sibility of cardiac poisoning from the oral administration of potas-
sium salts in this condition has been considered.17 Smillie"7 found
that death ensued shortly after oral administration of potassium salts
to rabbits with uranium nephritis. We have amplified his experi-
nients, using the dog as an experimental animal. Two factors were
found which make oral poisoning by potassium a difficult matter.
First, the pylorus shuts down as soon as a solution of potassium salts
enters the stomach, so that passage into the intestine and subsequent
re-absorption is much retarded. (This pylorospasm may be respon-
sible for the gastro-intestinal symptoms observed in man after the
oral administration of potassium salts.) Second, the rate of excre-
tion of potassium by the kidneys is normally so rapid that even when
potassium salts are introduced directly into the intestine a sufficient
elevation of potassium in the serum can only be obtained after the
ureters are ligated. Neither complete anuria nor direct entry of
potassium into the intestine commonly occurs in nephritis in man,
so these conditions necessary for experimental poisoning are wanting.
In a series of unpublished experiments of our own in which potas-
sium salts were administered to patients with advanced nephritis in
quantities sufficient to induce abdominal cramps and sometimes
vomiting, the maximum concentrations of serum potassium did not
exceed 32 mg. per cent. Thomson2" likewise failed to produce ele-
vations of potassium greater than these. Such concentrations in the
dog produce no demonstrable effects other than changes in the
amplitude of the T wave. Thus it is unlikely that in man cardiac
poisoning from ingestion of potassium occurs in renal insufficiency.
Spontaneous elevations of serum potassium are occasionally, but
not regularly, observed in late chronic nephritis in man16 and in
experimental acute anuria."2 These presumably result from a com-
bination of tissue breakdown and impairment or absence of excretion.
The concentration ofpotassium may attain a height sufficient to cause
serious cardiac damage, especially in anuria.
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It has been thought possible that the sudden death seen fre-
quently in Addison's disease might be due to cardiac arrest produced
by increased serum potassium. Since such increases are inconstant
and do not exceed approximately 12 mg. per cent,22 there is little
confirmation of this suggestion in animal experimentation. It is
possible, of course, that the
mSEU CA CONTROL heart in Addison's disease is
LO~" IJ i LJAAn peculiarly sensitive to small L0 fiJlJ LJJL L L/ increases in the concentration
FIRST INHIBITORY PHASE of potassium in the serum.
30A A A Thomson,2' however, found 30 'V u that in one case of Addison's
RAPID PHASE VENT. FIBRILLATION disease moderate fluctuations
50 AlL+ AIAA ~LI\ht~AA~..NAA of the concentration of potas-
X sium in serum were associated
SECOND INHIBITORY PHASE with no disturbances other
90 A A than changes in the height of
the T wave. Even higher
115 ARREST serum potassium values have been reported in dogs surviv-
FIG. 2. A diagramillustrating thechanges ing with adrenal insuffi-
in the electrocardiogram (Lead II) of the ciency P dog produced by the slow infusion of isotonic cec.~Tepsiiiyta
calcium chloride, with the average concentra- elevations of serum potassium
tions at which the several events occur. The in adrenal insufficiency may first inhibitory stage is of vagal origin, and
may be very pronounced. The second phase sometimes in themselves be
of acceleration is nearly always marked by fatal cannot be excluded. ventricular extra-systoles and tachycardia,
and may end in fatal ventricular fibrillation.
The final phase of slowing and arrest is, of Calcium
course, found only in animals surviving the
rapid phase, and is not of vagal origin. Three phases of calcium ac-
tivity were found in the dog:
Initial vagal bradycardia (serum concentration of calcium 15 to 35
nig. per cent); ventricular fibrillation (30 to 60 mg. per cent); and
ventricular arrest, occurring onlyin those escapingfibrillation, at con-
centrations greater than 60 mg. per cent. The dose of calcium
chloride usually injected therapeutically at one time does not exceed
1.0 gram. This cannot well produce a concentration in the serum
even temporarily exceeding 20 mg. per cent, so that only the first
two effects observed experimentally, vagal bradycardia and ven-
tricular fibrillation, are of clinical significance. The long arrest fol-
lowed by recovery reported in man by Lloyd9 after the injection of
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a very small amount of calcium probably represented an accentuation
of the usual vagal effect. Since even prolonged vagal stimulation is
seldom fatal, the occasional sudden death occurring during intra-
venous injection of calcium in patients3'27 is very probably due to
ventricular fibrillation. The lowest concentration at which this was
observed to occur in dogs was 30 mg. per cent, a concentration con-
siderably greater than that attained in man by the injection of the
customary therapeutic dose of calcium salts. This fact presumably
accounts for the rarity of such fatalities. It is, however, quite pos-
sible that very occasionally a heart might be peculiarly disposed to
the development of ventricular fibrillation, and so respond in this
way to an ordinarily innocuous concentration of calcium.
Calcium and Digitalis: The danger of sudden death during the
administration of calcium in digitalized patients has been empha-
sized.3 It has been suggested that the digitalized heart is peculiarly
sensitive to the toxic effects of calcium.5 Experimentally in dogs it
was impossible to find any evidence for such sensitivity.'9 Review
of the cases reported"9 indicates that patients probably died from
sudden ventricular fibrillation precipitated by calcium. Since this is
a characteristic toxic effect of calcium in normal animals, occurring
occasionally at concentrations as low as 30 mg. per cent, it is unneces-
sary to assume any special sensitivity imparted by digitalis. It is
simpler to suppose that certain diseased hearts are prone to the
development of fibrillation, and that the danger of the injection of
calcium to the digitalized patient is primarily the danger of the
injection of calcium in any patient with cardiac disease.
MAvagnesium
Magnesium injections in the dog produced: (1) Fall in blood
pressure associated with cutaneous vasodilatation (3 to 4 mg. per
cent of magnesium in serum); (2) partial, followed by complete,
neuromuscular block with respiratory arrest (12 to 20 mg. per cent
of magnesium in serum); (3) at concentrations considerably above
those at which spontaneous respiration ceased, cardiac block and
finally arrest. The initial effect of magnesium injection in man is
flushing accompanied by a rise in skin temperature and a sensation of
extreme warmth.' This is accompanied by a fall of blood pressure
and occurs after very small amounts of magnesium.6'26 Advantage
has been taken of this effect in the use of magnesium injections to
measure the velocity of circulation in man.""
" The fall in blood
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pressure continues during the injection and is associated with an
increase in thevolume of the extremities,6 accompanied by very little
change in cardiac rate or rhythm. It is probable, therefore, that it
is due to peripheral vasodilatation. The fall in blood pressure,
although it may be extreme, is not of the type associated with shock,
AVERAGE since muscular activity at
PR&QRS INTERVAL CARDIAC ARREST AVERAGE HEART any time results in a rapid
1-100 SECS. BEATS PERMIN eIevation of pressure"26
25 C X ~~~~~~~~HEART BLOCKt*1 25 HARTBLOK_-Twitch-like reflexes, mnHG RESPIRATORY ARREST
20 .200 .200 such as tendon jerks, dis-
P- >-O R appear at a relatively low
15 1 K X- 150 concentration, and are
0100 P-ATE 00 shortlyfollowedby uncon-
I QRS sciousness and respiratory
5 J BLOOD PRESSURE S0 arrest.", '" Therefore, the
01 ,0 \' .actual danger of its admin-
°0 J0 20 30 40 50 istration in man results
SERUM MAGNESIUM mg.X chieflyfromneuromuscular paralysis. There is nothing
FIG. 3. A chart showing the effect in the dog in the experimental results
of the level in the serum of magnesium sulfate on
the blood pressure, heart rate, A-V conduction obtained with animals to
(P-R), and intraventricular conduction (QRS). indicate that concentrations
The rectangles above indicate the concentrations
at which respiratory arrest, partial A-V block, sufficient to produce such
and sudden cardiac arrest may take place. No paralysis have any signifi-
significant alterations in the contour of the QRST h 8
complex are noted. cant effect on the heart.
This is borne out by serial
electrocardiograms, taken during the course of magnesium injections
in man, which fail to show any significant changes.26 Cardiac block
and eventual arrest occur at the much higher concentrations that can
be attained only if artificial respiration is employed. They are,
therefore, devoid of dinical significance and the value of magnesium
in the prevention of ectopic rhythms is questionable.
Magnesium sulfate injections have been employed in the treat-
ment of convulsive disorders of various types. In this dinic more
than fifty patients have been so treated without fatality, supporting
the contention that magnesium has no deleterious effects on the car-
diovascular system at concentrations consistent with the maintenance
of respiration. Since the knee-jerk and othertendon-jerks disappear
at a slightly lower level than does respiration in both man and ani-
mals, these reflexes serve as valuable guides in the therapeutic injec-
tion of magnesium.
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Barium
Barium is administered to man in very small doses only in order
to stimulate ventricular automaticity in cases of heart-block.4 The
caution in dosage emphasized by Cohn and Levine is amply justified
by our experiments, since ventricular fibrillation frequently followed
injection of very small Influence of Bariumon Blood Pressureand ECG amounts. The rationale of 300 mm.HG BLOOD PRESSURE-
its use to promote ventricu-
lar automaticity is con- A A C
firmed;2" the quantities 200
which are required to pro- FAA
duce this effect are, how- D I1\WJI
ever, little smaller than Vvv
those capable of evoking B0 I J
ventricular fibrillation. t .A1 X
0 1 Summary 0 O 5 10 15 20
1. The cardiovascular MINUTES
effects of the slow intrave- FIG. 4. A diagram showing the principal changes in the blood pressure and the electro-
nous infusion of salts of cardiogram (A, control) produced by the con-
potassium, calcium, magne- tinuous intravenous injection of barium in the pca magne- dog. Onset of injection (arrow) is almost imme- sium, and barium are re- diately followed by a marked increase in blood
viewed, pressure and the appearance of coupled ventricu-
lar extra-systoles (B). This arrhythmia may
2. The influence of give way to ventricular fibrillation (B'), and pro-
these ions may be correlated duce a fatal fall in blood pressure (broken line). If ventricular fibrillation does not develop the with their concentrations in blood pressure remains elevated for several min-
the serum. utes, and the electrocardiogram shows a ventricu-
lar tachycardia (C). Intraventricular block de- 3. Intraventricular velops (D) and pressure falls to zero. The heart
block and diastolic arrest later slows, block increases (E), and the heart
characterize the toxic influ- finally stops in diastole.
ence of potassium when injected intravenously.
4. It is unlikely that cardiac poisoning due to potassium ever
occurs in man, since dangerous concentrations cannot be attained in
the serum after oral administration.
5. Calcium produces in sequence (a) vagal bradycardia, (b)
ventricular arrhythmias, (c) ventricular fibrillation. Concentrations
sufficient to bring about the late diastolic arrest sometimes seen in
animals do not occur in clinical practice.
6. The initial effect of magnesium is vasodilatation with drop
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of blood pressure. Toxic effects on the heart appear only at con-
centrations incompatible with maintenance of spontaneous respiration
and are without clinical significance.
7. Fatal toxic effects in man are due to respiratory failure. Dis-
appearance of tendon-jerks is a sign of impending respiratory
failure.
8. Barium in small doses produces hypertension and ventricular
arrhythmias. Ventricular fibrillation frequently occurs.
9. With all ions the rate of infusion should be slow enough to
prevent the transitory development of high concentrations in the
coronary circulation.
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